Therefore, the blood concentration of PON1 was reduced in this way; then, the activity of the enzyme was influenced, which may increase the vulnerability to genomic damage by reducing the inflammatory oxidant and the detoxifying ability of dietary carcinogens, thereby increasing the risk of breast cancer [5]. The gene discussed is PON1; the disease is breast cancer.